Cell-free DNA and outcome in sepsis

Critical Care

Volumn 16, Issue 6, 2012, Pages

  Rhodes, Andrew ^a   Cecconi, Maurizio ^a  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; CELL FREE DNA; UNCLASSIFIED DRUG; DNA;

DISEASE SEVERITY; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; INTENSIVE CARE; MAJOR CLINICAL STUDY; NOTE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEPSIS; SURVIVAL; TREATMENT RESPONSE; BLOOD; FEMALE; MALE; MORTALITY;

DNA; FEMALE; HUMANS; MALE; SEPSIS;

EID: 84868702217     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11508     Document Type: Note

References (13)

1. Kehl DW, Iqbal N, Fard A, Kipper BA, De La Parra Landa A, Maisel AS. Biomarkers in acute myocardial injury. Transl Res 2012, 159:252-264. 10.1016/j.trsl.2011.11.002, 22424429.
2. Al-Subaie N, Reynolds T, Myers A, Sunderland R, Rhodes A, Grounds RM, Hall GM. C-reactive protein as a predictor of outcome after discharge from the intensive care: a prospective observational study. Br J Anaesth 2010, 105:318-325. 10.1093/bja/aeq171, 20630889.
3. Pierrakos C, Vincent J-L. Sepsis biomarkers: a review. Crit Care 2010, 14:R15. 10.1186/cc8872, 2875530, 20144219.
4. Butt AN, Swaminathan R. Overview of circulating nucleic acids in plasma/serum. Ann N Y Acad Sci 2008, 1137:236-242. 10.1196/annals.1448.002, 18837954.
5. Huttunen R, Kuparinen T, Jylhävä J, Aittoniemi J, Vuento R, Huhtala H, Laine J, Syrjänen J, Hurme M. Fatal outcome in bacteremia is characterized by high plasma cell free DNA concentration and apoptotic DNA fragmentation: a prospective cohort study. PLoS ONE 2011, 6:e21700. 10.1371/journal.pone.0021700, 3128600, 21747948.
6. Lo YM, Rainer TH, Chan LY, Hjelm NM, Cocks RA. Plasma DNA as a prognostic marker in trauma patients. Clin Chem 2000, 46:319-323.
7. Rainer TH, Wong KS, Lam W, Lam NYL, Graham CA, Lo YMD. Comparison of plasma beta-globin DNA and S-100 protein concentrations in acute stroke. Clin Chim Acta 2007, 376:190-196. 10.1016/j.cca.2006.08.025, 17027951.
8. Rhodes A, Wort SJ, Thomas H, Collinson P, Bennett ED. Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients. Crit Care 2006, 10:R60. 10.1186/cc4894, 1550922, 16613611.
9. Wijeratne S, Butt A, Burns S, Sherwood K, Boyd O, Swaminathan R. Cell-free plasma DNA as a prognostic marker in intensive treatment unit patients. Ann N Y Acad Sci 2004, 1022:232-238. 10.1196/annals.1318.036, 15251966.
10. Saukkonen K, Lakkisto P, Pettila V, Varpula M, Karlsson S, Ruokonen E, Pulkki K. Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock. Clin Chem 2008, 54:1000-1007. 10.1373/clinchem.2007.101030, 18420731.
11. Dwivedi DJ, Toltl LJ, Swystun LJ, Pogue J, Liaw KL, Weitz JI, Cook DJ, Fox-Robichaud AE, Liaw PC, . Canadian Critical Care Translational Biology Group Prognostic utility and characterization of cell-free DNA in patients with severe sepsis. Crit Care 2012, 16:R151. 10.1186/cc11466, 22889177, Canadian Critical Care Translational Biology Group.
12. Rainer TH, Chan AKC, Lee LLY, Yim VWT, Lam NYL, Yeung SW, Graham CA, Lo DYM. Use of plasma DNA to predict mortality and need for intensive care in patients with abdominal pain. Clin Chim Acta 2008, 398:113-117. 10.1016/j.cca.2008.08.022, 18801348.
13. Tovbin D, Novack V, Wiessman MP, Elkadir AA, Zlotnik M, Douvdevani A. Circulating cell-free DNA in hemodialysis patients predicts mortality. Nephrol Dial Transplant 2012, 27:3929-3935. 10.1093/ndt/gfs255, 22833622.